Effect of novel gene JAZF1 overexpression on glucose and lipid metabolism in 3T3-L1 adipocytes
10.3760/cma.j.issn.1000-6699.2010.07.020
- VernacularTitle:未知功能基因JAZF1过表达对3T3-L1脂肪细胞糖脂代谢的影响
- Author:
Yan YANG
;
Lin LI
;
Gangyi YANG
;
Bin SUN
;
Chunmin LU
;
Zongyu MIAO
- Publication Type:Journal Article
- Keywords:
JAZF1;
3T3-L1 cells;
Glucose metabolism;
Lipid metabolism;
Real-time quantitative PCR;
Lipid accumulation
- From:
Chinese Journal of Endocrinology and Metabolism
2010;26(7):595-598
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effects of JAZF1 (Juxtaposed with another zinc finger gene 1 ) overexpression on glucose and lipid metabolism in 3T3-L1 adipocytes. Methods The tissue distribution of JAZF1 in healthy C57BL/6J mice was detected by real-time quantitative PCR( RT-QPCR). Expression vector for JAZF1 gene was constructed and transfected into 3T3-L1 adipocytes. The mRNA levels of JAZF1, GLUT1, GLUT4, FAS, ACC, SREBP1, ATGL, and HSL implicated in glucose and lipid metabolism were determined by RT-QPCR; JAZF1 protein level was measured by Western blot. Intracelluar lipid accumulation were measured by oil red O staining method. Results In JAZF1-transfected adipocytes, JAZF1 mRNA and protein levels were significantly higher than control cells after 48 h. The mRNA level of HSL was increased significantly (P<0. 05) in JAZF1 transfection group compared with negative control and empty vector group, and the expressions of FAS, ACC, SREBP1 mRNA were decreased significantly(all P<0.01). However, the mRNA levels of ATGL, GLUT1, GLUT4 were not changed. Intracelluar lipid accumulation was decreased significantly (P<0.05 ) by oil red O staining and colorimetric in JAZF1 -transfected cells compared with negative control and empty vector group. Conclusions There was an extensive expression of JAZF1 in various tissues of C57BL/6J mice,indicating that JAZF1 might play a role in maintaining normal physiological function. These results show that overexpression of JAZF1 in 3T3-L1 cells can reduce lipid synthesis, increase lipolysis, and improve lipid accumulation. JAZF1 might provide a new potential therapeutic target for obesity and diabetes.
